Management costs of the Agency for health and disability insurance (HZIV/CAAMI): 2024 follow-up of the recommendations

In its 2022 audit, the Belgian Court of Audit examined how far HZIV/CAAMI kept its management costs under control, which were proportionately higher than those of other insurance bodies. It concluded that there was no guarantee that the funding received by HZIV/CAAMI for its management costs was used entirely for its intended purposes. The Court did not give an opinion on whether or not those management costs were too high given the limited basis for comparison with other insurance bodies, but considered that certain factors could justify the higher costs of HZIV/CAAMI. Ultimately, the Court was unable to conclude that the management costs of HZIV/CAAMI were sufficiently under control. In fact, due to the inadequate quality of planning, the Court had no reasonable assurance that the funding was allocated optimally. Despite the progress noted, the Court considers that the implementation level of its recommendations is low. Almost two years after the publication of the initial audit, four of the six recommendations have indeed not been followed and two are being implemented.